NM_018993.4:c.-36-2826C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_018993.4(RIN2):​c.-36-2826C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00483 in 1,545,556 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0029 ( 1 hom., cov: 29)
Exomes 𝑓: 0.0050 ( 41 hom. )

Consequence

RIN2
NM_018993.4 intron

Scores

1
14

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.304

Publications

3 publications found
Variant links:
Genes affected
RIN2 (HGNC:18750): (Ras and Rab interactor 2) The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]
RIN2 Gene-Disease associations (from GenCC):
  • RIN2 syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043200552).
BP6
Variant 20-19886740-C-T is Benign according to our data. Variant chr20-19886740-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 444566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00292 (444/151844) while in subpopulation NFE AF = 0.00539 (366/67964). AF 95% confidence interval is 0.00493. There are 1 homozygotes in GnomAd4. There are 200 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 41 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIN2NM_018993.4 linkc.-36-2826C>T intron_variant Intron 2 of 12 ENST00000255006.12 NP_061866.1 Q8WYP3-1A1A4T0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIN2ENST00000255006.12 linkc.-36-2826C>T intron_variant Intron 2 of 12 2 NM_018993.4 ENSP00000255006.7 Q8WYP3-1

Frequencies

GnomAD3 genomes
AF:
0.00293
AC:
444
AN:
151728
Hom.:
1
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000872
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00138
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000774
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00124
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00538
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00242
AC:
355
AN:
146716
AF XY:
0.00233
show subpopulations
Gnomad AFR exome
AF:
0.000427
Gnomad AMR exome
AF:
0.000593
Gnomad ASJ exome
AF:
0.000121
Gnomad EAS exome
AF:
0.00137
Gnomad FIN exome
AF:
0.00177
Gnomad NFE exome
AF:
0.00516
Gnomad OTH exome
AF:
0.00185
GnomAD4 exome
AF:
0.00503
AC:
7015
AN:
1393712
Hom.:
41
Cov.:
30
AF XY:
0.00491
AC XY:
3378
AN XY:
687434
show subpopulations
African (AFR)
AF:
0.000803
AC:
25
AN:
31146
American (AMR)
AF:
0.000755
AC:
26
AN:
34450
Ashkenazi Jewish (ASJ)
AF:
0.0000400
AC:
1
AN:
25008
East Asian (EAS)
AF:
0.000532
AC:
19
AN:
35722
South Asian (SAS)
AF:
0.000167
AC:
13
AN:
78050
European-Finnish (FIN)
AF:
0.00194
AC:
94
AN:
48374
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5666
European-Non Finnish (NFE)
AF:
0.00616
AC:
6640
AN:
1077322
Other (OTH)
AF:
0.00340
AC:
197
AN:
57974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
296
593
889
1186
1482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00292
AC:
444
AN:
151844
Hom.:
1
Cov.:
29
AF XY:
0.00270
AC XY:
200
AN XY:
74164
show subpopulations
African (AFR)
AF:
0.000869
AC:
36
AN:
41426
American (AMR)
AF:
0.00138
AC:
21
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000776
AC:
4
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4792
European-Finnish (FIN)
AF:
0.00124
AC:
13
AN:
10506
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00539
AC:
366
AN:
67964
Other (OTH)
AF:
0.00190
AC:
4
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
21
41
62
82
103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00358
Hom.:
0
Bravo
AF:
0.00294
TwinsUK
AF:
0.00782
AC:
29
ALSPAC
AF:
0.00415
AC:
16
ExAC
AF:
0.00118
AC:
25
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RIN2: BS2 -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 13, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

RIN2-related disorder Benign:1
May 31, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.4
DANN
Benign
0.85
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0053
N
LIST_S2
Benign
0.45
T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.30
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.13
N
REVEL
Benign
0.0080
Sift
Pathogenic
0.0
D
Vest4
0.076
MVP
0.17
MPC
0.20
ClinPred
0.028
T
GERP RS
-7.0
PromoterAI
-0.19
Neutral
gMVP
0.036
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183028833; hg19: chr20-19867384; API